SCHEMBL5578698

SCHEMBL5578698

CCS(=O)(=O)CCNCCc1nc2ccccc2c(=O)n1-c1ccc(OCC(F)(F)F)cc1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
PDE10A Q9Y233 8/20 0.51
KCNH2 Q12809 2/20 0.48
HRH3 Q9Y5N1 2/20 0.48
GAA P10253 1/20 0.48
LMNA P02545 1/20 0.46
MAPK1 P28482 1/20 0.46
ALDH1A1 P00352 1/20 0.45
BLM P54132 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
USP2 O75604 1/20 0.43
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5577400 0.90 MEN1 (0.56) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL5578378 0.82 PDE10A (0.58) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL1895441 0.82 PIK3CD (0.48) PDE10AKCNH2HRH3LMNAMAPK1
SCHEMBL1895439 0.82 PIK3CD (0.48) PDE10AKCNH2HRH3LMNAMAPK1
SCHEMBL5578380 0.76 PDE10A (0.53) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL4956988 0.75 LMNA (0.67) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL12659732 0.74 PIK3CD (0.48) PDE10AKCNH2HRH3MAPT
SCHEMBL12659747 0.73 HRH3 (0.54) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL1894544 0.72 CXCR3 (0.59) CYP3A4
SCHEMBL1894543 0.72 CXCR3 (0.59) CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1771447-A1 FUSED PYRIMIDINE DERIVATIVES AND COMPOSITIONS THEREOF AS CXCR3 RECEPTOR MODULATORS, USEFUL IN PREVENTION AND TREATMENT OF INFLAMMATORY AND IMMUNOREGULATORY DISORDERS AND DISEASES Amgen SF LLC (US) 2007-04-11 EP disclosed
WO-2006004915-A1 FUSED PYRIMIDINE DERIVATIVES AND COMPOSITIONS THEREOF AS CXCR3 RECEPTOR MODULATORS, USEFUL IN PREVENTION AND TREATMENT OF INFLAMMATORY AND IMMUNOREGULATORY DISORDERS AND DISEASES AMGEN SF, LLC (US) 2006-01-12 WO disclosed